메뉴 건너뛰기




Volumn 91, Issue , 2013, Pages 325-368

Endocannabinoids and Obesity

Author keywords

Body weight; Cannabinoid receptor; Cannabinoids; Endocannabinoid system; Food intake; Obesity

Indexed keywords


EID: 84873854908     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407766-9.00014-6     Document Type: Chapter
Times cited : (10)

References (238)
  • 1
    • 0015243053 scopus 로고
    • Effects of marihuana on the solution of anagrams, memory and appetite
    • Abel E.L. Effects of marihuana on the solution of anagrams, memory and appetite. Nature 1971, 231:260-261.
    • (1971) Nature , vol.231 , pp. 260-261
    • Abel, E.L.1
  • 2
    • 0016621840 scopus 로고
    • Cannabis: Effects on hunger and thirst
    • Abel E.L. Cannabis: Effects on hunger and thirst. Behavioral Biology 1975, 15:255-281.
    • (1975) Behavioral Biology , vol.15 , pp. 255-281
    • Abel, E.L.1
  • 3
    • 0031028923 scopus 로고    scopus 로고
    • Isolation and expression of a mouse CB1 cannabinoid receptor gene: Comparison of binding properties with those of native CB1 receptors in mouse brain and n18tg2 neuroblastoma cells
    • Abood M.E., Ditto K.E., Noel M.A., Showalter V.M., Tao Q. Isolation and expression of a mouse CB1 cannabinoid receptor gene: Comparison of binding properties with those of native CB1 receptors in mouse brain and n18tg2 neuroblastoma cells. Biochemical Pharmacology 1997, 53:207-214.
    • (1997) Biochemical Pharmacology , vol.53 , pp. 207-214
    • Abood, M.E.1    Ditto, K.E.2    Noel, M.A.3    Showalter, V.M.4    Tao, Q.5
  • 4
    • 0021124870 scopus 로고
    • Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds
    • Allyn C. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sciences 1984, 35:1803-1810.
    • (1984) Life Sciences , vol.35 , pp. 1803-1810
    • Allyn, C.1
  • 6
    • 0030738512 scopus 로고    scopus 로고
    • Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
    • Arnone M., Maruani J., Chaperon F., Thiébot M.H., Poncelet M., Soubrié P., et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 1997, 132:104-106.
    • (1997) Psychopharmacology , vol.132 , pp. 104-106
    • Arnone, M.1    Maruani, J.2    Chaperon, F.3    Thiébot, M.H.4    Poncelet, M.5    Soubrié, P.6
  • 9
    • 81155134826 scopus 로고    scopus 로고
    • Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss
    • Bennetzen M.F., Wellner N., Ahmed S.S., Ahmed S.M., Diep T.A., Hansen H.S., et al. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss. International Journal of Obesity 2011, 35:1377-1384.
    • (2011) International Journal of Obesity , vol.35 , pp. 1377-1384
    • Bennetzen, M.F.1    Wellner, N.2    Ahmed, S.S.3    Ahmed, S.M.4    Diep, T.A.5    Hansen, H.S.6
  • 10
    • 0037374766 scopus 로고    scopus 로고
    • The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
    • Bensaid M., Gary-Bobo M., Esclangon A., Maffrand J.P., Le Fur G., Oury-Donat F., et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Molecular Pharmacology 2003, 63:908-914.
    • (2003) Molecular Pharmacology , vol.63 , pp. 908-914
    • Bensaid, M.1    Gary-Bobo, M.2    Esclangon, A.3    Maffrand, J.P.4    Le Fur, G.5    Oury-Donat, F.6
  • 12
    • 0033198288 scopus 로고    scopus 로고
    • Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period
    • Berrendero F., Sepe N., Ramos J.A., Di Marzo V., Fernàndez-Ruiz J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999, 33:181-191.
    • (1999) Synapse , vol.33 , pp. 181-191
    • Berrendero, F.1    Sepe, N.2    Ramos, J.A.3    Di Marzo, V.4    Fernàndez-Ruiz, J.J.5
  • 13
    • 0036669295 scopus 로고    scopus 로고
    • Tetrahydrocannabinol and endocannabinoids in feeding and appetite
    • Berry E.M., Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacology & Therapeutics 2002, 95:185-190.
    • (2002) Pharmacology & Therapeutics , vol.95 , pp. 185-190
    • Berry, E.M.1    Mechoulam, R.2
  • 14
    • 10744229235 scopus 로고    scopus 로고
    • Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
    • Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. The Journal of Cell Biology 2003, 163:463-468.
    • (2003) The Journal of Cell Biology , vol.163 , pp. 463-468
    • Bisogno, T.1    Howell, F.2    Williams, G.3    Minassi, A.4    Cascio, M.G.5    Ligresti, A.6
  • 15
    • 33845522074 scopus 로고    scopus 로고
    • Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
    • Bláher M., Engeli S., KlÖting N., Berndt J., Fasshauer M., Bátkai S., et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 2006, 55:3053-3060.
    • (2006) Diabetes , vol.55 , pp. 3053-3060
    • Bláher, M.1    Engeli, S.2    Klöting, N.3    Berndt, J.4    Fasshauer, M.5    Bátkai, S.6
  • 18
    • 2142815151 scopus 로고    scopus 로고
    • Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity
    • Bray G.A., Nielsen S.J., Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. The American Journal of Clinical Nutrition 2004, 79:537-543.
    • (2004) The American Journal of Clinical Nutrition , vol.79 , pp. 537-543
    • Bray, G.A.1    Nielsen, S.J.2    Popkin, B.M.3
  • 19
    • 0032589999 scopus 로고    scopus 로고
    • Chronic D9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain
    • Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Vogt L.J., Sim-Selley L.J. Chronic D9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. Journal of Neurochemistry 1999, 73:2447-2459.
    • (1999) Journal of Neurochemistry , vol.73 , pp. 2447-2459
    • Breivogel, C.S.1    Childers, S.R.2    Deadwyler, S.A.3    Hampson, R.E.4    Vogt, L.J.5    Sim-Selley, L.J.6
  • 21
    • 0017645859 scopus 로고
    • Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of Δ9-tetrahydrocannabinol
    • Brown J.E., Kassouny M., Cross J.K. Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of Δ9-tetrahydrocannabinol. Behavioral Biology 1977, 20:104-110.
    • (1977) Behavioral Biology , vol.20 , pp. 104-110
    • Brown, J.E.1    Kassouny, M.2    Cross, J.K.3
  • 22
    • 0031594480 scopus 로고    scopus 로고
    • Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat
    • Buckley N.E., Hansson S., Harta G., Mezey é. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 1997, 82:1131-1149.
    • (1997) Neuroscience , vol.82 , pp. 1131-1149
    • Buckley, N.E.1    Hansson, S.2    Harta, G.3    Mezey, É.4
  • 24
    • 67650531422 scopus 로고    scopus 로고
    • Thematic review series: Proteomics. An integrated omics analysis of eicosanoid biology
    • Buczynski M.W., Dumlao D.S., Dennis E.A. Thematic review series: Proteomics. An integrated omics analysis of eicosanoid biology. Journal of Lipid Research 2009, 50:1015-1038.
    • (2009) Journal of Lipid Research , vol.50 , pp. 1015-1038
    • Buczynski, M.W.1    Dumlao, D.S.2    Dennis, E.A.3
  • 28
    • 77956037652 scopus 로고    scopus 로고
    • A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
    • Cluny N.L., Vemuri V.K., Chambers A.P., Limebeer C.L., Bedard H., Wood J.T., et al. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. British Journal of Pharmacology 2010, 161:629-642.
    • (2010) British Journal of Pharmacology , vol.161 , pp. 629-642
    • Cluny, N.L.1    Vemuri, V.K.2    Chambers, A.P.3    Limebeer, C.L.4    Bedard, H.5    Wood, J.T.6
  • 29
    • 33750374137 scopus 로고    scopus 로고
    • The twentieth century struggle to decipher insulin signalling
    • Cohen P. The twentieth century struggle to decipher insulin signalling. Nature Reviews. Molecular Cell Biology 2006, 7:867-873.
    • (2006) Nature Reviews. Molecular Cell Biology , vol.7 , pp. 867-873
    • Cohen, P.1
  • 30
    • 0033559313 scopus 로고    scopus 로고
    • Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp
    • Cohen S., Dadi H., Shaoul E., Sharfe N., Roifman C.M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999, 93:2013-2024.
    • (1999) Blood , vol.93 , pp. 2013-2024
    • Cohen, S.1    Dadi, H.2    Shaoul, E.3    Sharfe, N.4    Roifman, C.M.5
  • 31
    • 0025800169 scopus 로고
    • The actions of cyclic AMP on biosynthetic processes are mediated indirectly by cyclic AMP-dependent protein kinase
    • Cohen P., Grahame Hardie D. The actions of cyclic AMP on biosynthetic processes are mediated indirectly by cyclic AMP-dependent protein kinase. Biochimica et Biophysica Acta 1991, 1094:292-299.
    • (1991) Biochimica et Biophysica Acta , vol.1094 , pp. 292-299
    • Cohen, P.1    Grahame Hardie, D.2
  • 32
    • 0032541111 scopus 로고    scopus 로고
    • Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
    • Colombo G., Agabio R., Diaz G., Lobina C., Reali R., Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sciences 1998, 63:L113-L117.
    • (1998) Life Sciences , vol.63
    • Colombo, G.1    Agabio, R.2    Diaz, G.3    Lobina, C.4    Reali, R.5    Gessa, G.L.6
  • 33
    • 0030423694 scopus 로고    scopus 로고
    • In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity
    • Compton D.R., Aceto M.D., Lowe J., Martin B.R. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. The Journal of Pharmacology and Experimental Therapeutics 1996, 277:586-594.
    • (1996) The Journal of Pharmacology and Experimental Therapeutics , vol.277 , pp. 586-594
    • Compton, D.R.1    Aceto, M.D.2    Lowe, J.3    Martin, B.R.4
  • 35
    • 0042422112 scopus 로고    scopus 로고
    • Xenopus laevis CB1 cannabinoid receptor: Molecular cloning and mRNA distribution in the central nervous system
    • Cottone E., Salio C., Conrath M., Franzoni M.F. Xenopus laevis CB1 cannabinoid receptor: Molecular cloning and mRNA distribution in the central nervous system. The Journal of Comparative Neurology 2003, 464:487-496.
    • (2003) The Journal of Comparative Neurology , vol.464 , pp. 487-496
    • Cottone, E.1    Salio, C.2    Conrath, M.3    Franzoni, M.F.4
  • 37
    • 0029904838 scopus 로고    scopus 로고
    • Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
    • Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996, 384:83-87.
    • (1996) Nature , vol.384 , pp. 83-87
    • Cravatt, B.F.1    Giang, D.K.2    Mayfield, S.P.3    Boger, D.L.4    Lerner, R.A.5    Gilula, N.B.6
  • 39
    • 27844463517 scopus 로고    scopus 로고
    • Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
    • Després J.P., Golay A., SjÖstrÖm L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. The New England Journal of Medicine 2005, 353:2121-2134.
    • (2005) The New England Journal of Medicine , vol.353 , pp. 2121-2134
    • Després, J.P.1    Golay, A.2    Sjöström, L.3
  • 40
    • 61549116530 scopus 로고    scopus 로고
    • Effect of rimonabant on the high-triglyceride/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat
    • for the ADAGIO-Lipids Investigators
    • Després J.P., Ross R., Boka G., Alméras N., Lemieux I., for the ADAGIO-Lipids Investigators Effect of rimonabant on the high-triglyceride/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:416-423.
    • (2009) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.29 , pp. 416-423
    • Després, J.P.1    Ross, R.2    Boka, G.3    Alméras, N.4    Lemieux, I.5
  • 42
    • 0027078685 scopus 로고
    • Isolation and structure of a brain constituent that binds to the cannabinoid receptor
    • Devane W.A., HanuS L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
    • (1992) Science , vol.258 , pp. 1946-1949
    • Devane, W.A.1    HanuS, L.2    Breuer, A.3    Pertwee, R.G.4    Stevenson, L.A.5    Griffin, G.6
  • 43
    • 48249097797 scopus 로고    scopus 로고
    • Endocannabinoids: Synthesis and degradation
    • Springer: Berlin/Heidelberg
    • Di Marzo V. Endocannabinoids: Synthesis and degradation. Reviews of Physiology Biochemistry and Pharmacology 2008, 160:1-24. Springer: Berlin/Heidelberg.
    • (2008) Reviews of Physiology Biochemistry and Pharmacology , vol.160 , pp. 1-24
    • Di Marzo, V.1
  • 44
    • 43249100162 scopus 로고    scopus 로고
    • Targeting the endocannabinoid system: To enhance or reduce?
    • Di Marzo V. Targeting the endocannabinoid system: To enhance or reduce?. Nature Reviews. Drug Discovery 2008, 7:438-455.
    • (2008) Nature Reviews. Drug Discovery , vol.7 , pp. 438-455
    • Di Marzo, V.1
  • 45
    • 0033769188 scopus 로고    scopus 로고
    • Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice
    • Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., et al. Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice. Journal of Neurochemistry 2000, 75:2434-2444.
    • (2000) Journal of Neurochemistry , vol.75 , pp. 2434-2444
    • Di Marzo, V.1    Breivogel, C.S.2    Tao, Q.3    Bridgen, D.T.4    Razdan, R.K.5    Zimmer, A.M.6
  • 46
    • 58149471799 scopus 로고    scopus 로고
    • Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: Associations with changes in metabolic risk factors
    • Di Marzo V., Côté M., Matias I., Lemieux I., Arsenault B., Cartier A., et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: Associations with changes in metabolic risk factors. Diabetologia 2009, 52:213-217.
    • (2009) Diabetologia , vol.52 , pp. 213-217
    • Di Marzo, V.1    Côté, M.2    Matias, I.3    Lemieux, I.4    Arsenault, B.5    Cartier, A.6
  • 47
    • 70350347327 scopus 로고    scopus 로고
    • CB1 antagonists for obesity-What lessons have we learned from rimonabant?
    • Di Marzo V., Després J.P. CB1 antagonists for obesity-What lessons have we learned from rimonabant?. Nature Reviews. Endocrinology 2009, 5:633-638.
    • (2009) Nature Reviews. Endocrinology , vol.5 , pp. 633-638
    • Di Marzo, V.1    Després, J.P.2
  • 48
    • 0028589390 scopus 로고
    • Formation and inactivation of endogenous cannabinoid anandamide in central neurons
    • Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686-691.
    • (1994) Nature , vol.372 , pp. 686-691
    • Di Marzo, V.1    Fontana, A.2    Cadas, H.3    Schinelli, S.4    Cimino, G.5    Schwartz, J.C.6
  • 49
    • 0035848818 scopus 로고    scopus 로고
    • Leptin-regulated endocannabinoids are involved in maintaining food intake
    • Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825.
    • (2001) Nature , vol.410 , pp. 822-825
    • Di Marzo, V.1    Goparaju, S.K.2    Wang, L.3    Liu, J.4    Batkai, S.5    Jarai, Z.6
  • 50
    • 0035881542 scopus 로고    scopus 로고
    • Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells
    • Di Marzo V., Melck D., Orlando P., Bisogno T., Zagoory O., Bifulco M., et al. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. The Biochemical Journal 2001, 358:249-255.
    • (2001) The Biochemical Journal , vol.358 , pp. 249-255
    • Di Marzo, V.1    Melck, D.2    Orlando, P.3    Bisogno, T.4    Zagoory, O.5    Bifulco, M.6
  • 55
    • 79955921999 scopus 로고    scopus 로고
    • The differential effect of CB1 receptors on the discharge of afferent and efferent fibres supplying the rat jejunum
    • 567-e209
    • Donovan J., Grundy D. The differential effect of CB1 receptors on the discharge of afferent and efferent fibres supplying the rat jejunum. Neurogastroenterology and Motility 2011, 23. 567-e209.
    • (2011) Neurogastroenterology and Motility , vol.23
    • Donovan, J.1    Grundy, D.2
  • 56
    • 33845523338 scopus 로고    scopus 로고
    • Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats
    • Doyon C., Denis R.G., Baraboi E.D., Samson P., Lalonde J., Deshaies Y., et al. Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats. Diabetes 2006, 55:3403-3410.
    • (2006) Diabetes , vol.55 , pp. 3403-3410
    • Doyon, C.1    Denis, R.G.2    Baraboi, E.D.3    Samson, P.4    Lalonde, J.5    Deshaies, Y.6
  • 58
    • 61449252830 scopus 로고    scopus 로고
    • Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
    • Eckardt K., Sell H., Taube A., Koenen M., Platzbecker B., Cramer A., et al. Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 2009, 52:664-674.
    • (2009) Diabetologia , vol.52 , pp. 664-674
    • Eckardt, K.1    Sell, H.2    Taube, A.3    Koenen, M.4    Platzbecker, B.5    Cramer, A.6
  • 61
    • 57349088236 scopus 로고    scopus 로고
    • The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase
    • Esposito I., Proto M.C., Gazzerro P., Laezza C., Miele C., Alberobello A.T., et al. The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase. Molecular Pharmacology 2008, 74:1678-1686.
    • (2008) Molecular Pharmacology , vol.74 , pp. 1678-1686
    • Esposito, I.1    Proto, M.C.2    Gazzerro, P.3    Laezza, C.4    Miele, C.5    Alberobello, A.T.6
  • 63
  • 64
    • 34248532300 scopus 로고    scopus 로고
    • Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in rodents
    • Fong T.M., Guan X.M., Marsh D.J., Shen C.P., Stribling D.S., Rosko K.M., et al. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in rodents. The Journal of Pharmacology and Experimental Therapeutics 2007, 321:1013-1022.
    • (2007) The Journal of Pharmacology and Experimental Therapeutics , vol.321 , pp. 1013-1022
    • Fong, T.M.1    Guan, X.M.2    Marsh, D.J.3    Shen, C.P.4    Stribling, D.S.5    Rosko, K.M.6
  • 65
    • 70349128141 scopus 로고    scopus 로고
    • Cannabinoid-1 receptor inverse agonists: Current understanding of mechanism of action and unanswered questions
    • Fong T.M., Heymsfield S.B. Cannabinoid-1 receptor inverse agonists: Current understanding of mechanism of action and unanswered questions. International Journal of Obesity 2009, 33:947-955.
    • (2009) International Journal of Obesity , vol.33 , pp. 947-955
    • Fong, T.M.1    Heymsfield, S.B.2
  • 66
    • 0037661996 scopus 로고    scopus 로고
    • Role of endogenous cannabinoids in synaptic signaling
    • Freund T., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiological Reviews 2003, 83:1017-1066.
    • (2003) Physiological Reviews , vol.83 , pp. 1017-1066
    • Freund, T.1    Katona, I.2    Piomelli, D.3
  • 68
    • 2942716780 scopus 로고    scopus 로고
    • Modern science versus the stigma of obesity
    • Friedman J.M. Modern science versus the stigma of obesity. Nature Medicine 2004, 10:563-569.
    • (2004) Nature Medicine , vol.10 , pp. 563-569
    • Friedman, J.M.1
  • 70
    • 0344562864 scopus 로고    scopus 로고
    • A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene
    • Gadzicki D., Máller-Vahl K., Stuhrmann M. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Molecular and Cellular Probes 1999, 13:321-323.
    • (1999) Molecular and Cellular Probes , vol.13 , pp. 321-323
    • Gadzicki, D.1    Máller-Vahl, K.2    Stuhrmann, M.3
  • 72
    • 23944487985 scopus 로고    scopus 로고
    • Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
    • Gamber K.M., Macarthur H., Westfall T.C. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 2005, 49:646-652.
    • (2005) Neuropharmacology , vol.49 , pp. 646-652
    • Gamber, K.M.1    Macarthur, H.2    Westfall, T.C.3
  • 73
    • 33947489961 scopus 로고
    • Isolation, structure, and partial synthesis of an active constituent of hashish
    • Gaoni Y., Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society 1964, 86:1646-1647.
    • (1964) Journal of the American Chemical Society , vol.86 , pp. 1646-1647
    • Gaoni, Y.1    Mechoulam, R.2
  • 74
    • 31044456243 scopus 로고    scopus 로고
    • The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes
    • Gary-Bobo M., Elachouri G., Scatton B., Le Fur G., Oury-Donat F., Bensaid M. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Molecular Pharmacology 2006, 69:471-478.
    • (2006) Molecular Pharmacology , vol.69 , pp. 471-478
    • Gary-Bobo, M.1    Elachouri, G.2    Scatton, B.3    Le Fur, G.4    Oury-Donat, F.5    Bensaid, M.6
  • 76
    • 58149333713 scopus 로고    scopus 로고
    • Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes
    • Gaulton K.J., Willer C.J., Li Y., Scott L.J., Conneely K.N., Jackson A.U., et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 2008, 57:3136-3144.
    • (2008) Diabetes , vol.57 , pp. 3136-3144
    • Gaulton, K.J.1    Willer, C.J.2    Li, Y.3    Scott, L.J.4    Conneely, K.N.5    Jackson, A.U.6
  • 77
    • 0025878961 scopus 로고
    • Molecular cloning of a human cannabinoid receptor which is also expressed in testis
    • Gérard C.M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. The Biochemical Journal 1991, 279:129-134.
    • (1991) The Biochemical Journal , vol.279 , pp. 129-134
    • Gérard, C.M.1    Mollereau, C.2    Vassart, G.3    Parmentier, M.4
  • 78
    • 0016139071 scopus 로고
    • Effects of Δ9-THC on food and water intake of deprivation experienced rats
    • Gluck J.P., Ferraro D.P. Effects of Δ9-THC on food and water intake of deprivation experienced rats. Behavioral Biology 1974, 11:395-401.
    • (1974) Behavioral Biology , vol.11 , pp. 395-401
    • Gluck, J.P.1    Ferraro, D.P.2
  • 84
    • 0014622071 scopus 로고
    • Psychopharmacological activity of the active constituents of hashish and some related cannabinoids
    • Grunfeld Y., Edery H. Psychopharmacological activity of the active constituents of hashish and some related cannabinoids. Psychopharmacology 1969, 14:200-210.
    • (1969) Psychopharmacology , vol.14 , pp. 200-210
    • Grunfeld, Y.1    Edery, H.2
  • 85
    • 0043162058 scopus 로고    scopus 로고
    • Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain
    • Hanus L., Avraham Y., Ben-Shushan D., Zolotarev O., Berry E.M., Mechoulam R. Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. Brain Research 2003, 983:144-151.
    • (2003) Brain Research , vol.983 , pp. 144-151
    • Hanus, L.1    Avraham, Y.2    Ben-Shushan, D.3    Zolotarev, O.4    Berry, E.M.5    Mechoulam, R.6
  • 87
    • 0034737597 scopus 로고    scopus 로고
    • Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
    • Hao S., Avraham Y., Mechoulam R., Berry E.M. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. European Journal of Pharmacology 2000, 392:147-156.
    • (2000) European Journal of Pharmacology , vol.392 , pp. 147-156
    • Hao, S.1    Avraham, Y.2    Mechoulam, R.3    Berry, E.M.4
  • 88
    • 0018194701 scopus 로고
    • Evidence for the existence of specific cannabinoid binding sites
    • Harris L.S., Carchman R.A., Martin B.R. Evidence for the existence of specific cannabinoid binding sites. Life Sciences 1978, 22:1131-1137.
    • (1978) Life Sciences , vol.22 , pp. 1131-1137
    • Harris, L.S.1    Carchman, R.A.2    Martin, B.R.3
  • 90
    • 0025954862 scopus 로고
    • Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
    • Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. The Journal of Neuroscience 1991, 11:563-583.
    • (1991) The Journal of Neuroscience , vol.11 , pp. 563-583
    • Herkenham, M.1    Lynn, A.B.2    Johnson, M.R.3    Melvin, L.S.4    de Costa, B.R.5    Rice, K.C.6
  • 92
    • 42449164329 scopus 로고    scopus 로고
    • Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed Wistar rats
    • Herling A.W., Kilp S., Elvert R., Haschke G., Kramer W. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed Wistar rats. Endocrinology 2008, 149:2557-2566.
    • (2008) Endocrinology , vol.149 , pp. 2557-2566
    • Herling, A.W.1    Kilp, S.2    Elvert, R.3    Haschke, G.4    Kramer, W.5
  • 93
    • 12344318287 scopus 로고    scopus 로고
    • Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain
    • Hermann H., Lutz B. Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain. Neuroscience Letters 2005, 375:13-18.
    • (2005) Neuroscience Letters , vol.375 , pp. 13-18
    • Hermann, H.1    Lutz, B.2
  • 94
    • 35648944276 scopus 로고    scopus 로고
    • GPR55 and the vascular receptors for cannabinoids
    • Hiley C.R., Kaup S.S. GPR55 and the vascular receptors for cannabinoids. British Journal of Pharmacology 2007, 152:559-561.
    • (2007) British Journal of Pharmacology , vol.152 , pp. 559-561
    • Hiley, C.R.1    Kaup, S.S.2
  • 96
    • 77649260031 scopus 로고    scopus 로고
    • Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: The ARPEGGIO trial
    • for the ARPEGGIO Study Group
    • Hollander P.A., Amod A., Litwak L.E., Chaudhari U., for the ARPEGGIO Study Group Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: The ARPEGGIO trial. Diabetes Care 2010, 33:605-607.
    • (2010) Diabetes Care , vol.33 , pp. 605-607
    • Hollander, P.A.1    Amod, A.2    Litwak, L.E.3    Chaudhari, U.4
  • 97
    • 0015207811 scopus 로고
    • Marihuana in man: Three years later
    • Hollister L.E. Marihuana in man: Three years later. Science 1971, 172:21-29.
    • (1971) Science , vol.172 , pp. 21-29
    • Hollister, L.E.1
  • 99
    • 0021722983 scopus 로고
    • Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes
    • Howlett A.C., Fleming R.M. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Molecular Pharmacology 1984, 26:532-538.
    • (1984) Molecular Pharmacology , vol.26 , pp. 532-538
    • Howlett, A.C.1    Fleming, R.M.2
  • 100
    • 0023914862 scopus 로고
    • Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model
    • Howlett A.C., Johnson M.R., Melvin L.S., Milne G.M. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Molecular Pharmacology 1988, 33:297-302.
    • (1988) Molecular Pharmacology , vol.33 , pp. 297-302
    • Howlett, A.C.1    Johnson, M.R.2    Melvin, L.S.3    Milne, G.M.4
  • 101
    • 34247895688 scopus 로고    scopus 로고
    • Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: Implications for cannabinoid actions on food intake and cognitive arousal
    • Huang H., Acuna-Goycolea C., Li Y., Cheng H.M., Obrietan K., van den Pol A.N. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: Implications for cannabinoid actions on food intake and cognitive arousal. The Journal of Neuroscience 2007, 27:4870-4881.
    • (2007) The Journal of Neuroscience , vol.27 , pp. 4870-4881
    • Huang, H.1    Acuna-Goycolea, C.2    Li, Y.3    Cheng, H.M.4    Obrietan, K.5    van den Pol, A.N.6
  • 102
    • 0034740564 scopus 로고    scopus 로고
    • Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
    • Izzo A.A., Fezza F., Capasso R., Bisogno T., Pinto L., Iuvone T., et al. Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. British Journal of Pharmacology 2001, 134:563-570.
    • (2001) British Journal of Pharmacology , vol.134 , pp. 563-570
    • Izzo, A.A.1    Fezza, F.2    Capasso, R.3    Bisogno, T.4    Pinto, L.5    Iuvone, T.6
  • 103
    • 2442651556 scopus 로고    scopus 로고
    • Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif
    • Jagerovic N., Hernandez-Folgado L., Alkorta I., Goya P., Navarro M., Serrano A., et al. Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif. Journal of Medicinal Chemistry 2004, 47:2939-2942.
    • (2004) Journal of Medicinal Chemistry , vol.47 , pp. 2939-2942
    • Jagerovic, N.1    Hernandez-Folgado, L.2    Alkorta, I.3    Goya, P.4    Navarro, M.5    Serrano, A.6
  • 104
    • 0035185205 scopus 로고    scopus 로고
    • Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
    • Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. British Journal of Pharmacology 2001, 134:1151-1154.
    • (2001) British Journal of Pharmacology , vol.134 , pp. 1151-1154
    • Jamshidi, N.1    Taylor, D.A.2
  • 106
    • 24644500204 scopus 로고    scopus 로고
    • The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance
    • Jbilo O., Ravinet-Trillou C., Arnone M., Buisson I., Bribes E., Péleraux A., et al. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. The FASEB Journal 2005, 19:1567-1569.
    • (2005) The FASEB Journal , vol.19 , pp. 1567-1569
    • Jbilo, O.1    Ravinet-Trillou, C.2    Arnone, M.3    Buisson, I.4    Bribes, E.5    Péleraux, A.6
  • 107
    • 58249105329 scopus 로고    scopus 로고
    • Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2
    • Jelsing J., Galzin A.M., Guillot E., Pruniaux M.P., Larsen P.J., Vrang N. Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2. Brain Research Bulletin 2009, 78:202-210.
    • (2009) Brain Research Bulletin , vol.78 , pp. 202-210
    • Jelsing, J.1    Galzin, A.M.2    Guillot, E.3    Pruniaux, M.P.4    Larsen, P.J.5    Vrang, N.6
  • 108
    • 38649114788 scopus 로고    scopus 로고
    • Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver
    • Jeong W.I., Osei-Hyiaman D., Park O., Liu J., Bátkai S., Mukhopadhyay P., et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metabolism 2008, 7:227-235.
    • (2008) Cell Metabolism , vol.7 , pp. 227-235
    • Jeong, W.I.1    Osei-Hyiaman, D.2    Park, O.3    Liu, J.4    Bátkai, S.5    Mukhopadhyay, P.6
  • 110
    • 57049102251 scopus 로고    scopus 로고
    • End of the line for cannabinoid receptor 1 as an anti-obesity target?
    • Jones D. End of the line for cannabinoid receptor 1 as an anti-obesity target?. Nature Reviews. Drug Discovery 2008, 7:961-962.
    • (2008) Nature Reviews. Drug Discovery , vol.7 , pp. 961-962
    • Jones, D.1
  • 111
    • 77951184370 scopus 로고    scopus 로고
    • CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice
    • Jourdan T., Djaouti L., Demizieux L., Gresti J., Vergès B., Degrace P. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice. Diabetes 2010, 59:926-934.
    • (2010) Diabetes , vol.59 , pp. 926-934
    • Jourdan, T.1    Djaouti, L.2    Demizieux, L.3    Gresti, J.4    Vergès, B.5    Degrace, P.6
  • 114
  • 115
  • 116
    • 79953216705 scopus 로고    scopus 로고
    • Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells
    • Kim W., Doyle M.E., Liu Z., Lao Q., Shin Y.K., Carlson O.D., et al. Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells. Diabetes 2011, 60:1198-1209.
    • (2011) Diabetes , vol.60 , pp. 1198-1209
    • Kim, W.1    Doyle, M.E.2    Liu, Z.3    Lao, Q.4    Shin, Y.K.5    Carlson, O.D.6
  • 117
    • 77952290508 scopus 로고    scopus 로고
    • A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes
    • Kipnes M.S., Hollander P., Fujioka K., Gantz I., Seck T., Erondu N., et al. A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes. Diabetes, Obesity & Metabolism 2010, 12:517-531.
    • (2010) Diabetes, Obesity & Metabolism , vol.12 , pp. 517-531
    • Kipnes, M.S.1    Hollander, P.2    Fujioka, K.3    Gantz, I.4    Seck, T.5    Erondu, N.6
  • 118
    • 0035984946 scopus 로고    scopus 로고
    • Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-arachidonoyl glycerol
    • Kirkham T.C., Williams C.M., Fezza F., Marzo V.D. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-arachidonoyl glycerol. British Journal of Pharmacology 2002, 136:550-557.
    • (2002) British Journal of Pharmacology , vol.136 , pp. 550-557
    • Kirkham, T.C.1    Williams, C.M.2    Fezza, F.3    Marzo, V.D.4
  • 119
    • 45549092924 scopus 로고    scopus 로고
    • The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system
    • Kola B., Farkas I., Christ-Crain M., Wittmann G., Lolli F., Amin F., et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One 2008, 3:e1797.
    • (2008) PLoS One , vol.3
    • Kola, B.1    Farkas, I.2    Christ-Crain, M.3    Wittmann, G.4    Lolli, F.5    Amin, F.6
  • 120
    • 21644453934 scopus 로고    scopus 로고
    • Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase
    • Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. The Journal of Biological Chemistry 2005, 280:25196-25201.
    • (2005) The Journal of Biological Chemistry , vol.280 , pp. 25196-25201
    • Kola, B.1    Hubina, E.2    Tucci, S.A.3    Kirkham, T.C.4    Garcia, E.A.5    Mitchell, S.E.6
  • 122
    • 0033555839 scopus 로고    scopus 로고
    • Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
    • Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999, 283:401-404.
    • (1999) Science , vol.283 , pp. 401-404
    • Ledent, C.1    Valverde, O.2    Cossu, G.3    Petitet, F.4    Aubert, J.F.5    Beslot, F.6
  • 123
    • 59349103952 scopus 로고    scopus 로고
    • Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion
    • Linari G., Agostini S., Amadoro G., Ciotti M.T., Florenzano F., Improta G., et al. Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion. Pharmacological Research 2009, 59:207-214.
    • (2009) Pharmacological Research , vol.59 , pp. 207-214
    • Linari, G.1    Agostini, S.2    Amadoro, G.3    Ciotti, M.T.4    Florenzano, F.5    Improta, G.6
  • 124
    • 77449118145 scopus 로고    scopus 로고
    • Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells
    • Lipina C., Stretton C., Hastings S., Hundal J.S., Mackie K., Irving A.J., et al. Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells. Diabetes 2010, 59:375-385.
    • (2010) Diabetes , vol.59 , pp. 375-385
    • Lipina, C.1    Stretton, C.2    Hastings, S.3    Hundal, J.S.4    Mackie, K.5    Irving, A.J.6
  • 125
    • 13244249625 scopus 로고    scopus 로고
    • Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
    • Liu Y.L., Connoley I.P., Wilson C.A., Stock M.J. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice. International Journal of Obesity and Related Metabolic Disorders 2004, 29:183-187.
    • (2004) International Journal of Obesity and Related Metabolic Disorders , vol.29 , pp. 183-187
    • Liu, Y.L.1    Connoley, I.P.2    Wilson, C.A.3    Stock, M.J.4
  • 127
  • 128
    • 35348864420 scopus 로고    scopus 로고
    • Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward
    • Mahler S.V., Smith K.S., Berridge K.C. Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 2007, 32:2267-2278.
    • (2007) Neuropsychopharmacology , vol.32 , pp. 2267-2278
    • Mahler, S.V.1    Smith, K.S.2    Berridge, K.C.3
  • 129
    • 0015236718 scopus 로고
    • Inhibition of normal growth by chronic administration of Δ-9-tetrahydrocannabinol
    • Manning F.J., McDonough J.H., Elsmore T.F., Saller C., Sodetz F.J. Inhibition of normal growth by chronic administration of Δ-9-tetrahydrocannabinol. Science 1971, 174:424-426.
    • (1971) Science , vol.174 , pp. 424-426
    • Manning, F.J.1    McDonough, J.H.2    Elsmore, T.F.3    Saller, C.4    Sodetz, F.J.5
  • 130
    • 0033452718 scopus 로고    scopus 로고
    • Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain
    • Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. The European Journal of Neuroscience 1999, 11:4213-4225.
    • (1999) The European Journal of Neuroscience , vol.11 , pp. 4213-4225
    • Marsicano, G.1    Lutz, B.2
  • 131
    • 0022448676 scopus 로고
    • Cellular effects of cannabinoids
    • Martin B.R. Cellular effects of cannabinoids. Pharmacological Reviews 1986, 38:45-74.
    • (1986) Pharmacological Reviews , vol.38 , pp. 45-74
    • Martin, B.R.1
  • 133
    • 33847403181 scopus 로고    scopus 로고
    • Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1
    • Martini L., Waldhoer M., Pusch M., Kharazia V., Fong J., Lee J.H., et al. Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1. The FASEB Journal 2007, 21:802-811.
    • (2007) The FASEB Journal , vol.21 , pp. 802-811
    • Martini, L.1    Waldhoer, M.2    Pusch, M.3    Kharazia, V.4    Fong, J.5    Lee, J.H.6
  • 136
    • 0037123850 scopus 로고    scopus 로고
    • Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain
    • Mato S., Pazos A., Valdizán E.M. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain. European Journal of Pharmacology 2002, 443:43-46.
    • (2002) European Journal of Pharmacology , vol.443 , pp. 43-46
    • Mato, S.1    Pazos, A.2    Valdizán, E.M.3
  • 137
    • 0025325535 scopus 로고
    • Structure of a cannabinoid receptor and functional expression of the cloned cDNA
    • Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
    • (1990) Nature , vol.346 , pp. 561-564
    • Matsuda, L.A.1    Lolait, S.J.2    Brownstein, M.J.3    Young, A.C.4    Bonner, T.I.5
  • 139
    • 0014933381 scopus 로고
    • Marihuana chemistry
    • Mechoulam R. Marihuana chemistry. Science 1970, 168:1159-1166.
    • (1970) Science , vol.168 , pp. 1159-1166
    • Mechoulam, R.1
  • 140
  • 142
    • 0033660254 scopus 로고    scopus 로고
    • A historical overview of chemical research on cannabinoids
    • Mechoulam R., Hanuš L. A historical overview of chemical research on cannabinoids. Chemistry and Physics of Lipids 2000, 108:1-13.
    • (2000) Chemistry and Physics of Lipids , vol.108 , pp. 1-13
    • Mechoulam, R.1    Hanuš, L.2
  • 144
    • 1242337340 scopus 로고    scopus 로고
    • Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain
    • Miller C.C., Murray T.F., Freeman K.G., Edwards G.L. Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain. Physiology & Behavior 2004, 80:611-616.
    • (2004) Physiology & Behavior , vol.80 , pp. 611-616
    • Miller, C.C.1    Murray, T.F.2    Freeman, K.G.3    Edwards, G.L.4
  • 145
    • 1842484296 scopus 로고    scopus 로고
    • AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
    • Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
    • (2004) Nature , vol.428 , pp. 569-574
    • Minokoshi, Y.1    Alquier, T.2    Furukawa, N.3    Kim, Y.B.4    Lee, A.5    Xue, B.6
  • 148
    • 35649000942 scopus 로고    scopus 로고
    • Genetic dissection of behavioural and autonomic effects of Δ9-tetrahydrocannabinol in mice
    • Monory K., Blaudzun H., Massa F., Kaiser N., Lemberger T., Schátz G., et al. Genetic dissection of behavioural and autonomic effects of Δ9-tetrahydrocannabinol in mice. PLoS Biology 2007, 5:e269.
    • (2007) PLoS Biology , vol.5
    • Monory, K.1    Blaudzun, H.2    Massa, F.3    Kaiser, N.4    Lemberger, T.5    Schátz, G.6
  • 149
    • 19344363569 scopus 로고    scopus 로고
    • Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa
    • Monteleone P., Matias I., Martiadis V., De Petrocellis L., Maj M., Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 2005, 30:1216-1221.
    • (2005) Neuropsychopharmacology , vol.30 , pp. 1216-1221
    • Monteleone, P.1    Matias, I.2    Martiadis, V.3    De Petrocellis, L.4    Maj, M.5    Di Marzo, V.6
  • 150
    • 48749100198 scopus 로고    scopus 로고
    • The CB1 endocannabinoid system modulates adipocyte insulin sensitivity
    • Motaghedi R., McGraw T.E. The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. Obesity 2008, 16:1727-1734.
    • (2008) Obesity , vol.16 , pp. 1727-1734
    • Motaghedi, R.1    McGraw, T.E.2
  • 152
    • 77953486365 scopus 로고    scopus 로고
    • Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor
    • Mukhopadhyay B., Liu J., Osei-Hyiaman D., Godlewski G., Mukhopadhyay P., Wang L., et al. Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor. The Journal of Biological Chemistry 2010, 285:19002-19011.
    • (2010) The Journal of Biological Chemistry , vol.285 , pp. 19002-19011
    • Mukhopadhyay, B.1    Liu, J.2    Osei-Hyiaman, D.3    Godlewski, G.4    Mukhopadhyay, P.5    Wang, L.6
  • 153
    • 0027515373 scopus 로고
    • Molecular characterization of a peripheral receptor for cannabinoids
    • Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
    • (1993) Nature , vol.365 , pp. 61-65
    • Munro, S.1    Thomas, K.L.2    Abu-Shaar, M.3
  • 154
    • 37349059404 scopus 로고    scopus 로고
    • Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors
    • Nakata M., Yada T. Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors. Regulatory Peptides 2008, 145:49-53.
    • (2008) Regulatory Peptides , vol.145 , pp. 49-53
    • Nakata, M.1    Yada, T.2
  • 157
    • 58149128824 scopus 로고    scopus 로고
    • Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats
    • Nogueiras R., Veyrat-Durebex C., Suchanek P.M., Klein M., TschÖp J., Caldwell C., et al. Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes 2008, 57:2977-2991.
    • (2008) Diabetes , vol.57 , pp. 2977-2991
    • Nogueiras, R.1    Veyrat-Durebex, C.2    Suchanek, P.M.3    Klein, M.4    Tschöp, J.5    Caldwell, C.6
  • 158
    • 81055156684 scopus 로고    scopus 로고
    • Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation
    • Nomura D.K., Morrison B.E., Blankman J.L., Long J.Z., Kinsey S.G., Marcondes M.C., et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 2011, 334:809-813.
    • (2011) Science , vol.334 , pp. 809-813
    • Nomura, D.K.1    Morrison, B.E.2    Blankman, J.L.3    Long, J.Z.4    Kinsey, S.G.5    Marcondes, M.C.6
  • 159
    • 58149485817 scopus 로고    scopus 로고
    • Human obesity as a heritable disorder of the central control of energy balance
    • O'Rahilly S., Farooqi I.S. Human obesity as a heritable disorder of the central control of energy balance. International Journal of Obesity 2008, 32:S55-S61.
    • (2008) International Journal of Obesity , vol.32
    • O'Rahilly, S.1    Farooqi, I.S.2
  • 162
    • 20944436157 scopus 로고    scopus 로고
    • Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
    • Osei-Hyiaman D., DePetrillo M., Pacher P., Liu J., Radaeva S., Bátkai S., et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. The Journal of Clinical Investigation 2005, 115:1298-1305.
    • (2005) The Journal of Clinical Investigation , vol.115 , pp. 1298-1305
    • Osei-Hyiaman, D.1    DePetrillo, M.2    Pacher, P.3    Liu, J.4    Radaeva, S.5    Bátkai, S.6
  • 163
    • 51349153318 scopus 로고    scopus 로고
    • Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
    • Osei-Hyiaman D., Liu J., Zhou L., Godlewski G., Harvey-White J., Jeong W.I., et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. The Journal of Clinical Investigation 2008, 118:3160-3169.
    • (2008) The Journal of Clinical Investigation , vol.118 , pp. 3160-3169
    • Osei-Hyiaman, D.1    Liu, J.2    Zhou, L.3    Godlewski, G.4    Harvey-White, J.5    Jeong, W.I.6
  • 164
    • 0027196816 scopus 로고
    • Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study
    • Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study. Brain Research 1993, 616:293-302.
    • (1993) Brain Research , vol.616 , pp. 293-302
    • Oviedo, A.1    Glowa, J.2    Herkenham, M.3
  • 165
    • 33748703859 scopus 로고    scopus 로고
    • The endocannabinoid system as an emerging target of pharmacotherapy
    • Pacher P., Btkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews 2006, 58:389-462.
    • (2006) Pharmacological Reviews , vol.58 , pp. 389-462
    • Pacher, P.1    Btkai, S.2    Kunos, G.3
  • 166
    • 80053276336 scopus 로고    scopus 로고
    • The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice
    • Pang Z., Wu N.N., Zhao W., Chain D.C., Schaffer E., Zhang X., et al. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice. Obesity 2011, 19:1923-1934.
    • (2011) Obesity , vol.19 , pp. 1923-1934
    • Pang, Z.1    Wu, N.N.2    Zhao, W.3    Chain, D.C.4    Schaffer, E.5    Zhang, X.6
  • 168
    • 33746110406 scopus 로고    scopus 로고
    • Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole-LH 21
    • Pavon F.J., Bilbao A., Hernández-Folgado L., Cippitelli A., Jagerovic N., Abellán G., et al. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole-LH 21. Neuropharmacology 2006, 51:358-366.
    • (2006) Neuropharmacology , vol.51 , pp. 358-366
    • Pavon, F.J.1    Bilbao, A.2    Hernández-Folgado, L.3    Cippitelli, A.4    Jagerovic, N.5    Abellán, G.6
  • 169
    • 0035010955 scopus 로고    scopus 로고
    • Cannabinoids and the gastrointestinal tract
    • Pertwee R.G. Cannabinoids and the gastrointestinal tract. Gut 2001, 48:859-867.
    • (2001) Gut , vol.48 , pp. 859-867
    • Pertwee, R.G.1
  • 170
    • 73349119690 scopus 로고    scopus 로고
    • Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes
    • Perwitz N., Wenzel J., Wagner I., Báning J., Drenckhan M., Zarse K., et al. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes. Diabetes, Obesity and Metabolism 2010, 12:158-166.
    • (2010) Diabetes, Obesity and Metabolism , vol.12 , pp. 158-166
    • Perwitz, N.1    Wenzel, J.2    Wagner, I.3    Báning, J.4    Drenckhan, M.5    Zarse, K.6
  • 171
    • 0037026745 scopus 로고    scopus 로고
    • Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus
    • Petersen K.F., Shulman G.I. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. The American Journal of Cardiology 2002, 90:11-18.
    • (2002) The American Journal of Cardiology , vol.90 , pp. 11-18
    • Petersen, K.F.1    Shulman, G.I.2
  • 173
    • 32644441249 scopus 로고    scopus 로고
    • Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients
    • for the RIO-North America Study Group
    • Pi-Sunyer F.X., Aronne L.J., Heshmati H.M., Devin J., Rosenstock J., for the RIO-North America Study Group Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. JAMA: The Journal of the American Medical Association 2006, 295:761-775.
    • (2006) JAMA: The Journal of the American Medical Association , vol.295 , pp. 761-775
    • Pi-Sunyer, F.X.1    Aronne, L.J.2    Heshmati, H.M.3    Devin, J.4    Rosenstock, J.5
  • 177
    • 77955472298 scopus 로고    scopus 로고
    • A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: Low-dose study
    • Proietto J., Rissanen A., Harp J.B., Erondu N., Yu Q., Suryawanshi S., et al. A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: Low-dose study. International Journal of Obesity 2010, 34:1243-1254.
    • (2010) International Journal of Obesity , vol.34 , pp. 1243-1254
    • Proietto, J.1    Rissanen, A.2    Harp, J.B.3    Erondu, N.4    Yu, Q.5    Suryawanshi, S.6
  • 179
    • 77950199353 scopus 로고    scopus 로고
    • CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance
    • Quarta C., Bellocchio L., Mancini G., Mazza R., Cervino C., Braulke L.J., et al. CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metabolism 2010, 11:273-285.
    • (2010) Cell Metabolism , vol.11 , pp. 273-285
    • Quarta, C.1    Bellocchio, L.2    Mancini, G.3    Mazza, R.4    Cervino, C.5    Braulke, L.J.6
  • 183
    • 0036015112 scopus 로고    scopus 로고
    • CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one)]-induced hypothermia
    • Rawls S.M., Cabassa J., Geller E.B., Adler M.W. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one)]-induced hypothermia. The Journal of Pharmacology and Experimental Therapeutics 2002, 301:963-968.
    • (2002) The Journal of Pharmacology and Experimental Therapeutics , vol.301 , pp. 963-968
    • Rawls, S.M.1    Cabassa, J.2    Geller, E.B.3    Adler, M.W.4
  • 184
    • 22844449583 scopus 로고    scopus 로고
    • The insulin resistance syndrome: Definition and dietary approaches to treatment
    • Reaven G.M. The insulin resistance syndrome: Definition and dietary approaches to treatment. Annual Review of Nutrition 2005, 25:391-406.
    • (2005) Annual Review of Nutrition , vol.25 , pp. 391-406
    • Reaven, G.M.1
  • 186
    • 84855678493 scopus 로고    scopus 로고
    • A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men
    • Riggs P.K., Vaida F., Rossi S.S., Sorkin L.S., Gouaux B., Grant I., et al. A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. Brain Research 2012, 1431:46-52.
    • (2012) Brain Research , vol.1431 , pp. 46-52
    • Riggs, P.K.1    Vaida, F.2    Rossi, S.S.3    Sorkin, L.S.4    Gouaux, B.5    Grant, I.6
  • 190
    • 0030959336 scopus 로고    scopus 로고
    • Effects of chronic exposure to D9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions
    • Romero J., Garcia-Palomero E., Castro J.G., Garcia-Gil L., Ramos J.A., Fernandez-Ruiz J.J. Effects of chronic exposure to D9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Molecular Brain Research 1997, 46:100-108.
    • (1997) Molecular Brain Research , vol.46 , pp. 100-108
    • Romero, J.1    Garcia-Palomero, E.2    Castro, J.G.3    Garcia-Gil, L.4    Ramos, J.A.5    Fernandez-Ruiz, J.J.6
  • 194
    • 11144263163 scopus 로고    scopus 로고
    • Identification and characterisation of a novel splice variant of the human CB1 receptor
    • Ryberg E., Vu H.K., Larsson N., Groblewski T., Hjorth S., Elebring T., et al. Identification and characterisation of a novel splice variant of the human CB1 receptor. FEBS Letters 2005, 579:259-264.
    • (2005) FEBS Letters , vol.579 , pp. 259-264
    • Ryberg, E.1    Vu, H.K.2    Larsson, N.3    Groblewski, T.4    Hjorth, S.5    Elebring, T.6
  • 195
    • 33751001942 scopus 로고    scopus 로고
    • Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: A randomised controlled study
    • Scheen A.J., Finer N., Hollander P., Jensen M.D., Van Gaal L.F. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: A randomised controlled study. The Lancet 2006, 368:1660-1672.
    • (2006) The Lancet , vol.368 , pp. 1660-1672
    • Scheen, A.J.1    Finer, N.2    Hollander, P.3    Jensen, M.D.4    Van Gaal, L.F.5
  • 196
    • 17444423605 scopus 로고    scopus 로고
    • Primary prevention of diabetes: What can be done and how much can be prevented?
    • Schulze M.B., Hu F.B. Primary prevention of diabetes: What can be done and how much can be prevented?. Annual Review of Public Health 2005, 26:445-467.
    • (2005) Annual Review of Public Health , vol.26 , pp. 445-467
    • Schulze, M.B.1    Hu, F.B.2
  • 200
    • 0015650106 scopus 로고
    • Influence of tetrahydrocannabinols (Δ8-THC and Δ9-THC) on body weight, food, and water intake in rats
    • SjÖdén P.O., Järbe T.U.C., Henriksson B.G. Influence of tetrahydrocannabinols (Δ8-THC and Δ9-THC) on body weight, food, and water intake in rats. Pharmacology, Biochemistry, and Behavior 1973, 1:395-399.
    • (1973) Pharmacology, Biochemistry, and Behavior , vol.1 , pp. 395-399
    • Sjödén, P.O.1    Järbe, T.U.C.2    Henriksson, B.G.3
  • 201
    • 0035087553 scopus 로고    scopus 로고
    • Zebra finch CB1 cannabinoid receptor: Pharmacology and in vivo and in vitro effects of activation
    • Soderstrom K., Johnson F. Zebra finch CB1 cannabinoid receptor: Pharmacology and in vivo and in vitro effects of activation. The Journal of Pharmacology and Experimental Therapeutics 2001, 297:189-197.
    • (2001) The Journal of Pharmacology and Experimental Therapeutics , vol.297 , pp. 189-197
    • Soderstrom, K.1    Johnson, F.2
  • 202
    • 0033625543 scopus 로고    scopus 로고
    • Behavioral, pharmacological, and molecular characterization of an amphibian cannabinoid receptor
    • Soderstrom K., Leid M., Moore F.L., Murray T.F. Behavioral, pharmacological, and molecular characterization of an amphibian cannabinoid receptor. Journal of Neurochemistry 2000, 75:413-423.
    • (2000) Journal of Neurochemistry , vol.75 , pp. 413-423
    • Soderstrom, K.1    Leid, M.2    Moore, F.L.3    Murray, T.F.4
  • 203
    • 0016285821 scopus 로고
    • Acute and chronic effects of δ9-tetrahydrocannabinol on food intake by rats
    • Sofia R.D., Barry H. Acute and chronic effects of δ9-tetrahydrocannabinol on food intake by rats. Psychopharmacology 1974, 39:213-222.
    • (1974) Psychopharmacology , vol.39 , pp. 213-222
    • Sofia, R.D.1    Barry, H.2
  • 204
    • 77949539755 scopus 로고    scopus 로고
    • Peripherally acting CB1-receptor antagonist: The relative importance of central and peripheral CB1 receptors in adiposity control
    • Son M.H., Kim H.D., Chae Y.N., Kim M.K., Shin C.Y., Ahn G.J., et al. Peripherally acting CB1-receptor antagonist: The relative importance of central and peripheral CB1 receptors in adiposity control. International Journal of Obesity 2010, 34:547-556.
    • (2010) International Journal of Obesity , vol.34 , pp. 547-556
    • Son, M.H.1    Kim, H.D.2    Chae, Y.N.3    Kim, M.K.4    Shin, C.Y.5    Ahn, G.J.6
  • 205
    • 79954629673 scopus 로고    scopus 로고
    • Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice
    • Song D., Bandsma R., Xiao C., Xi L., Shao W., Jin T., et al. Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. Diabetologia 2011, 54:1181-1189.
    • (2011) Diabetologia , vol.54 , pp. 1181-1189
    • Song, D.1    Bandsma, R.2    Xiao, C.3    Xi, L.4    Shao, W.5    Jin, T.6
  • 206
    • 34547574943 scopus 로고    scopus 로고
    • Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus
    • Soria-GÓmez E., Matias I., Rueda-Orozco P.E., Cisneros M., Petrosino S., Navarro L., et al. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. British Journal of Pharmacology 2007, 151:1109-1116.
    • (2007) British Journal of Pharmacology , vol.151 , pp. 1109-1116
    • Soria-GÓmez, E.1    Matias, I.2    Rueda-Orozco, P.E.3    Cisneros, M.4    Petrosino, S.5    Navarro, L.6
  • 211
  • 213
    • 0017295234 scopus 로고
    • Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue
    • Tornqvist H., Belfrage P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. The Journal of Biological Chemistry 1976, 251:813-819.
    • (1976) The Journal of Biological Chemistry , vol.251 , pp. 813-819
    • Tornqvist, H.1    Belfrage, P.2
  • 214
    • 79955635993 scopus 로고    scopus 로고
    • Role of cannabinoid receptors in alcoholic hepatic injury: Steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
    • Trebicka J., Racz I., Siegmund S.V., Cara E., Granzow M., Schierwagen R., et al. Role of cannabinoid receptors in alcoholic hepatic injury: Steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver International 2011, 31:860-870.
    • (2011) Liver International , vol.31 , pp. 860-870
    • Trebicka, J.1    Racz, I.2    Siegmund, S.V.3    Cara, E.4    Granzow, M.5    Schierwagen, R.6
  • 215
    • 0031929438 scopus 로고    scopus 로고
    • Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
    • Tsou K., Brown S., Sañudo-Peña M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1997, 83:393-411.
    • (1997) Neuroscience , vol.83 , pp. 393-411
    • Tsou, K.1    Brown, S.2    Sañudo-Peña, M.C.3    Mackie, K.4    Walker, J.M.5
  • 216
    • 75749126604 scopus 로고    scopus 로고
    • Signal transduction of the CB1 cannabinoid receptor
    • Turu G., Hunyady L. Signal transduction of the CB1 cannabinoid receptor. Journal of Molecular Endocrinology 2010, 44:75-85.
    • (2010) Journal of Molecular Endocrinology , vol.44 , pp. 75-85
    • Turu, G.1    Hunyady, L.2
  • 218
    • 51749109070 scopus 로고    scopus 로고
    • Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)
    • van Diepen H., Schlicker E., Michel M. Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716). Naunyn-Schmiedeberg's Archives of Pharmacology 2008, 378:345-369.
    • (2008) Naunyn-Schmiedeberg's Archives of Pharmacology , vol.378 , pp. 345-369
    • van Diepen, H.1    Schlicker, E.2    Michel, M.3
  • 219
    • 42449136138 scopus 로고    scopus 로고
    • Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: Two year results from the RIO-Europe Study
    • Van Gaal L.F., Scheen A.J., Rissanen A.M., RÖssner S., Hanotin C., Ziegler O. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: Two year results from the RIO-Europe Study. European Heart Journal 2008, 29:1761-1771.
    • (2008) European Heart Journal , vol.29 , pp. 1761-1771
    • Van Gaal, L.F.1    Scheen, A.J.2    Rissanen, A.M.3    Rössner, S.4    Hanotin, C.5    Ziegler, O.6
  • 220
    • 58849117501 scopus 로고    scopus 로고
    • The effects of rimonabant on brown adipose tissue in rat: Implications for energy expenditure
    • Verty A.N.A., Allen A.M., Oldfield B.J. The effects of rimonabant on brown adipose tissue in rat: Implications for energy expenditure. Obesity 2008, 17:254-261.
    • (2008) Obesity , vol.17 , pp. 254-261
    • Verty, A.N.A.1    Allen, A.M.2    Oldfield, B.J.3
  • 221
    • 4143144159 scopus 로고    scopus 로고
    • The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol
    • Verty A.N.A., McGregor I.S., Mallet P.E. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol. Brain Research 2004, 1020:188-195.
    • (2004) Brain Research , vol.1020 , pp. 188-195
    • Verty, A.N.A.1    McGregor, I.S.2    Mallet, P.E.3
  • 222
    • 0038070321 scopus 로고    scopus 로고
    • Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats
    • Vickers S.P., Webster L.J., Wyatt A., Dourish C.T., Kennett G.A. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology 2003, 167:103-111.
    • (2003) Psychopharmacology , vol.167 , pp. 103-111
    • Vickers, S.P.1    Webster, L.J.2    Wyatt, A.3    Dourish, C.T.4    Kennett, G.A.5
  • 223
    • 78649954020 scopus 로고    scopus 로고
    • A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet
    • Wadden T.A., Fujioka K., Toubro S., Gantz I., Erondu E., Chen M., et al. A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet. Obesity 2010, 18:2301-2310.
    • (2010) Obesity , vol.18 , pp. 2301-2310
    • Wadden, T.A.1    Fujioka, K.2    Toubro, S.3    Gantz, I.4    Erondu, E.5    Chen, M.6
  • 224
    • 79953007668 scopus 로고    scopus 로고
    • Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum
    • Wang X., Horswill J.G., Whalley B.J., Stephens G.J. Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum. Molecular Pharmacology 2011, 79:758-767.
    • (2011) Molecular Pharmacology , vol.79 , pp. 758-767
    • Wang, X.1    Horswill, J.G.2    Whalley, B.J.3    Stephens, G.J.4
  • 225
    • 79952008057 scopus 로고    scopus 로고
    • Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity
    • Wang Q., Perrard X.D., Perrard J.L., Mansoori A., Smith C.W., Ballantyne C.M., et al. Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity. Obesity 2011, 19:505-513.
    • (2011) Obesity , vol.19 , pp. 505-513
    • Wang, Q.1    Perrard, X.D.2    Perrard, J.L.3    Mansoori, A.4    Smith, C.W.5    Ballantyne, C.M.6
  • 226
    • 72049098786 scopus 로고    scopus 로고
    • Thrift: A guide to thrifty genes, thrifty phenotypes and thrifty norms
    • Wells J.C.K. Thrift: A guide to thrifty genes, thrifty phenotypes and thrifty norms. International Journal of Obesity 2009, 33:1331-1338.
    • (2009) International Journal of Obesity , vol.33 , pp. 1331-1338
    • Wells, J.C.K.1
  • 227
    • 0032936642 scopus 로고    scopus 로고
    • Anandamide induces overeating: Mediation by central cannabinoid (CB1) receptors
    • Williams C.M., Kirkham T.C. Anandamide induces overeating: Mediation by central cannabinoid (CB1) receptors. Psychopharmacology 1999, 143:315-317.
    • (1999) Psychopharmacology , vol.143 , pp. 315-317
    • Williams, C.M.1    Kirkham, T.C.2
  • 228
    • 0036607403 scopus 로고    scopus 로고
    • Observational analysis of feeding induced by Δ9-THC and anandamide
    • Williams C.M., Kirkham T.C. Observational analysis of feeding induced by Δ9-THC and anandamide. Physiology & Behavior 2002, 76:241-250.
    • (2002) Physiology & Behavior , vol.76 , pp. 241-250
    • Williams, C.M.1    Kirkham, T.C.2
  • 229
    • 0036361973 scopus 로고    scopus 로고
    • Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
    • Williams C.M., Kirkham T.C. Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacology, Biochemistry, and Behavior 2002, 71:333-340.
    • (2002) Pharmacology, Biochemistry, and Behavior , vol.71 , pp. 333-340
    • Williams, C.M.1    Kirkham, T.C.2
  • 232
    • 0017129553 scopus 로고
    • 9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols
    • Wilson R.S., May E.L., Martin B.R., Dewey W.L. 9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols. Journal of Medicinal Chemistry 1976, 19:1165-1167.
    • (1976) Journal of Medicinal Chemistry , vol.19 , pp. 1165-1167
    • Wilson, R.S.1    May, E.L.2    Martin, B.R.3    Dewey, W.L.4
  • 233
    • 70149106339 scopus 로고    scopus 로고
    • Adipose-specific phospholipase as regulator of adiposity
    • Wolf G. Adipose-specific phospholipase as regulator of adiposity. Nutrition Reviews 2009, 67:551-554.
    • (2009) Nutrition Reviews , vol.67 , pp. 551-554
    • Wolf, G.1
  • 234
    • 0030219719 scopus 로고    scopus 로고
    • Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubripes
    • Yamaguchi F., Macrae A.D., Brenner S. Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubripes. Genomics 1996, 35:603-605.
    • (1996) Genomics , vol.35 , pp. 603-605
    • Yamaguchi, F.1    Macrae, A.D.2    Brenner, S.3
  • 235
    • 79952793112 scopus 로고    scopus 로고
    • Obesity prevalence in the United States: Up, down, or sideways?
    • Yanovski S.Z., Yanovski J.A. Obesity prevalence in the United States: Up, down, or sideways?. The New England Journal of Medicine 2011, 364:987-989.
    • (2011) The New England Journal of Medicine , vol.364 , pp. 987-989
    • Yanovski, S.Z.1    Yanovski, J.A.2
  • 236
    • 77956253088 scopus 로고    scopus 로고
    • Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters
    • Zhao W., Fong O., Muise E.S., Thompson J.R., Weingarth D., Qian S., et al. Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters. Molecular Pharmacology 2010, 78:350-359.
    • (2010) Molecular Pharmacology , vol.78 , pp. 350-359
    • Zhao, W.1    Fong, O.2    Muise, E.S.3    Thompson, J.R.4    Weingarth, D.5    Qian, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.